Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Otto

Showing results (71-80 of 199) with videos related to

Pageof 20
Sort By:
Behavioral Neuroscience|February 1, 1995
Entorhinal-perirhinal lesions impair performance of rats on two versions of place learning in the Morris water mazeA H Nagahara, T Otto, M Gallagher
Behavioral and Neural Biology|January 1, 1992
The hippocampus--what does it do?H Eichenbaum, T Otto, N J Cohen
MMW Fortschritte Der Medizin|April 29, 2000
[Therapy of prostate carcinoma. Age, general health status and stage determine choice of therapy]T Otto, M H Seegenschmiedt, H Rübben
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1993
[Therapeutic strategies in patients with bladder tumors according to histopathological findings]T Otto, S al Enzawi, H Rübben
Annales D'Urologie|January 1, 1992
[Treatment of clinical stage I and IIA non-seminomatous, germ cell testicular tumors]T Otto, H Behrendt, N Niederle, et al.
Der Urologe. Ausg. A|March 1, 1996
[Pediatric ureteral ureteral outlet obstruction and obstructive megaureter: observation or operation?]M Goepel, B Lettgen, T Otto, et al.
Der Urologe. Ausg. A|November 19, 2003
[Therapy of advanced penis carcinoma]T Otto, J Suhr, S Krege, et al.
Urologia Internationalis|November 22, 2002
Phase II study of repeated single 24-hour infusion of low-dose 5-fluorouracil for palliation in symptomatic hormone-refractory prostate cancerA Bex, T Otto, G Lümmen, et al.
Urology|February 13, 2001
Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trialT Otto, S Krege, J Suhr, et al.
Der Urologe. Ausg. A|June 7, 2005
[New aspects in hernia surgery]B J Lammers, P E Goretzki, T Otto
Pageof 20

Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
Behavioral Neuroscience|February 1, 1995
Entorhinal-perirhinal lesions impair performance of rats on two versions of place learning in the Morris water mazeA H Nagahara, T Otto, M Gallagher
Behavioral and Neural Biology|January 1, 1992
The hippocampus--what does it do?H Eichenbaum, T Otto, N J Cohen
MMW Fortschritte Der Medizin|April 29, 2000
[Therapy of prostate carcinoma. Age, general health status and stage determine choice of therapy]T Otto, M H Seegenschmiedt, H Rübben
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1993
[Therapeutic strategies in patients with bladder tumors according to histopathological findings]T Otto, S al Enzawi, H Rübben
Annales D'Urologie|January 1, 1992
[Treatment of clinical stage I and IIA non-seminomatous, germ cell testicular tumors]T Otto, H Behrendt, N Niederle, et al.
Der Urologe. Ausg. A|March 1, 1996
[Pediatric ureteral ureteral outlet obstruction and obstructive megaureter: observation or operation?]M Goepel, B Lettgen, T Otto, et al.
Der Urologe. Ausg. A|November 19, 2003
[Therapy of advanced penis carcinoma]T Otto, J Suhr, S Krege, et al.
Urologia Internationalis|November 22, 2002
Phase II study of repeated single 24-hour infusion of low-dose 5-fluorouracil for palliation in symptomatic hormone-refractory prostate cancerA Bex, T Otto, G Lümmen, et al.
Urology|February 13, 2001
Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trialT Otto, S Krege, J Suhr, et al.
Der Urologe. Ausg. A|June 7, 2005
[New aspects in hernia surgery]B J Lammers, P E Goretzki, T Otto
Pageof 20